NUS Nu Skin Enterprises, Inc.

NYSE
$3.80

Nu Skin Enterprises, Inc. (NUS) is expected to report earnings on February 4, 2027, after the market close. The consensus earnings estimate is $0.16 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -11.8% since its last earnings release on November 5, 2026.

Nu Skin Enterprises Missed Consensus Estimates, Lowers Guidance
Thursday, November 5, 2026 · 4:06 PM ET
Earnings Date
4th Quarter, Dec 2026
Feb 4
Thursday · 4:05 PM ET
Earnings Whisper
-
vs $0.16
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $3.97

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Nu Skin Enterprises, Inc.

Nu Skin Enterprises Inc is a direct selling company, which develops and distributes anti-aging personal care products and nutritional supplements that are sold under the Nu Skin and Pharmanex category brands.

Sector

Staples

Industry

Personal Products

Held By 1 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.